[HTML][HTML] The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane …

A Slepenkin, S Pal, S Hoang-Phou… - Vaccines, 2023 - mdpi.com
Chlamydia trachomatis is the most common bacterial sexually transmitted pathogen. The
number of chlamydial infections continuous to increase and there is an urgent need for a …

[引用][C] The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane …

A Slepenkin, S Pal, S Hoang-Phou… - 2023 - europepmc.org
Chlamydia trachomatis is the most common bacterial sexually transmitted pathogen. The
number of chlamydial infections continuous to increase and there is an urgent need for a …

Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C …

S Pal, A Favaroni, DF Tifrea, PT Hanisch, SET Luczak… - Vaccine, 2017 - Elsevier
Objectives To test vaccines, formulated with novel antigens, to protect mice against
Chlamydia infections. Methods To determine the ability of polymorphic membrane proteins …

Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital …

H Yu, KP Karunakaran, X Jiang, RC Brunham - Vaccine, 2014 - Elsevier
An efficacious vaccine is needed to control Chlamydia trachomatis infection. In the murine
model of Chlamydia muridarum genital infection, multifunctional mucosal CD4 T cells are …

Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4+ cells in C57BL/6N mice

T Mosolygó, ÁM Szabó, EP Balogh, I Faludi, DP Virók… - Vaccine, 2014 - Elsevier
Urogenital tract infection with Chlamydia trachomatis is a leading cause of sexually
transmitted infections. There is currently no commercially available vaccine against C …

Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology

T Müller, E Becker, S Stallmann, A Waldhuber… - Vaccine, 2017 - Elsevier
Chlamydia trachomatis serovars DK are one of the most frequent causes of sexually
transmitted infections of the female genital tract, with possible complications such as …

[HTML][HTML] A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response …

C Cheng, S Pal, D Tifrea, Z Jia, LM de la Maza - Microbes and infection, 2014 - Elsevier
Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen in the
World and there is a need for a vaccine. To enhance the immunogenicity of a vaccine …

Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with …

S Pal, EM Peterson, LM de la Maza - Infection and immunity, 2005 - Am Soc Microbiol
ABSTRACT BALB/c mice were vaccinated by the intramuscular (im) and subcutaneous (sc)
routes with a native preparation of the Chlamydia trachomatis mouse pneumonitis (MoPn) …

Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen

R Hadad, E Marks, I Kalbina, K Schön, M Unemo… - APMIS, 2016 - Wiley Online Library
The asymptomatic nature of most Chlamydia trachomatis infections and the lack of
appropriate effects by current prevention and management call for vaccine development. We …

Dissociation of immune determinants of outer membrane proteins of Chlamydia psittaci strain guinea pig inclusion conjunctivitis

TD Westbay, CC Dascher, RC Hsia… - Infection and …, 1994 - Am Soc Microbiol
Chlamydia trachomatis is an important human pathogen. Research to develop a Chlamydia
vaccine has focused on the major outer membrane protein (MOMP). Determinants of this …